Participation of the TRPV1 receptor in the development of acute gout attacks

Rheumatology (United Kingdom)

Volumn 53, Issue 2, 2014, Pages 240-249

  Hoffmeister, Carin ^a   Silva, Mariane Arnoldi ^a   Rossato, Mateus Fortes ^a   Trevisan, Gabriela ^a   Oliveira, Sara Marchesan ^a   Guerra, Gustavo Petri ^b   Silva, Cassia Regina ^a   Ferreira, Juliano ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b UNIVERSIDADE TECNOLÓGICA FEDERAL DO PARANÁ   (Brazil)

Author keywords

Arthritis; Mast cell; Sensory neuron; TRPV1 antagonist; Vanilloid receptor

Indexed keywords

4 CHLORO N (3 METHOXYPHENYL)CINNAMAMIDE; INTERLEUKIN 1BETA; URATE; VANILLOID RECEPTOR 1;

ACUTE DISEASE; ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANKLE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CRYSTAL; CYTOKINE PRODUCTION; DEGRANULATION; DISEASE COURSE; EDEMA; EXTRAVASATION; GOUT; HYPERALGESIA; IMMUNOREACTIVITY; INFLAMMATION; LEUKOCYTE; MALE; MAST CELL; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; SENSORY NERVE CELL;

ARTHRITIS; MAST CELL; SENSORY NEURON; TRPV1 ANTAGONIST; VANILLOID RECEPTOR;

ACUTE DISEASE; ANILIDES; ANIMALS; ARTHRALGIA; CINNAMATES; DISEASE MODELS, ANIMAL; GOUT; INFLAMMATION; MALE; RATS; RATS, WISTAR; TRPV CATION CHANNELS; URIC ACID;

EID: 84892546712     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ket352     Document Type: Article

References (44)

1. Neogi T. Clinical practice. Gout. N Engl J Med 2011;364: 443-52.
2. Dalbeth N, Haskard DO. Mechanisms of inflammation in gout. Rheumatology 2005;44:1090-6.
3. Martinon F, Pétrilli V, Mayor A et al. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006;440:237-41.
4. Keith MP, Gilliland WR. Updates in the management of gout. Am J Med 2007;120:221-4.
5. Lindsay K, Gow P, Vanderpyl J et al. The experience and impact of living with gout: a study of men with chronic gout using a qualitative grounded theory approach. J Clin Rheumatol 2011;17:1-6.
6. Ferreira J, da Silva GL, Calixto JB. Contribution of vanilloid receptors to the overt nociception induced by B2 kinin receptor activation in mice. Br J Pharmacol 2004;141: 787-94.
7. Engler A, Aeschlimann A, Simmen BR et al. Expression of transient receptor potential vanilloid 1 (TRPV1) in synovial fibroblasts from patients with osteoarthritis and rheumatoid arthritis. Biochem Biophys Res Commun 2007;359:884-8.
8. Matsukawa A, Yoshimura T, Maeda T et al. Analysis of the cytokine network among tumor necrosis factor alpha, interleukin-1beta, interleukin-8, and interleukin-1 receptor antagonist in monosodium urate crystal-induced rabbit arthritis. Lab Invest 1998;78:559-69.
9. Keeble J, Russell F, Curtis B et al. Involvement of transient receptor potential vanilloid 1 in the vascular and hyperalgesic components of joint inflammation. Arthritis Rheum 2005;52:3248-56.
10. Barton NJ, McQueen DS, Thomson D et al. Attenuation of experimental arthritis in TRPV1R knockout mice. Exp Mol Pathol 2006;81:166-70.
11. Valdes AM, De Wilde G, Doherty SA et al. The Ile585Val TRPV1 variant is involved in risk of painful knee osteoarthritis. Ann Rheum Dis 2011;70: 1556-61.
12. Coderre TJ, Wall PD. Ankle joint urate arthritis in rats provides a useful tool for the evaluation of analgesic and anti-arthritic agents. Pharmacol Biochem Behav 1988; 29:461-6.
13. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983;16: 109-10.
14. Hoffmeister C, Trevisan G, Rossato MF et al. Role of TRPV1 in nociception and edema induced by monosodium urate crystals in rats. Pain 2011;152:1777-88.
15. Silva MA, Trevisan G, Klafke JZ et al. Antinociceptive and anti-inflammatory effects of Aloe saponaria Haw on thermal injury in rats. J Ethnopharmacol 2013;146: 393-401.
16. Pinto LG, Cunha TM, Vieira SM et al. IL-17 mediates articular hypernociception in antigen-induced arthritis in mice. Pain 2010;148:247-56.
17. Davis AJ, Perkins MN. Substance P and capsaicininduced mechanical hyperalgesia in the rat knee joint; the involvement of bradykinin B1 and B2 receptors. Br J Pharmacol 1996;118:2206-12.
18. Gewehr C, da Silva MA, dos Santos GT et al. Contribution of peripheral vanilloid receptor to the nociception induced by injection of spermine in mice. Pharmacol Biochem Behav 2011;99:775-81.
19. Steiner AA, Turek VF, Almeida MC et al. Nonthermal activation of transient receptor potential vanilloid-1 channels in abdominal viscera tonically inhibits autonomic cold-defense effectors. J Neurosci 2007;27: 7459-68.
20. Brenneis C, Kistner K, Puopolo M et al. Phenotyping the function of TRPV1-expressing sensory neurons by targeted axonal silencing. J Neurosci 2013;33:315-26.
21. Lam FY, Ferrell WR. Neurogenic component of different models of acute inflammation in the rat knee joint. Ann Rheum Dis 1991;50:747-51.
22. Faires JS, McCarty DJ Jr. Acute arthritis in man and dog after intrasynovial injection of sodium urate crystals. Lancet 1962;2:682-5.
23. Caterina MJ, Leffler A, Malmberg AB et al. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 2000;288:306-13.
24. Nuki G, Simkin PA. A concise history of gout and hyperuricemia and their treatment. Arthritis Res Ther 2006; 8(Suppl 1):S1.
25. Schumacher HR, Phelps P, Agudelo CA. Urate crystal induced inflammation in dog joints: sequence of synovial changes. J Rheumatol 1974;1:102-13.
26. Deal CL, Schnitzer TJ, Lipstein E et al. Treatment of arthritis with topical capsaicin: a double-blind trial. Clin Ther 1991;13:383-95.
27. Cathcart CJ, Johnston SA, Reynolds LR et al. Efficacy of ABT-116, an antagonist of transient receptor potential vanilloid type 1, in providing analgesia for dogs with chemically induced synovitis. Am J Vet Res 2012;73: 19-26.
28. Gavva NR, Treanor JJ, Garami A et al. Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans. Pain 2008;136:202-10.
29. Terkeltaub R. Update on gout: new therapeutic strategies and options. Nat Rev Rheumatol 2010;6:30-8.
30. Szallasi A, Cortright DN, Blum CA et al. The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept. Nat Rev Drug Discov 2007;6: 357-72.
31. VanItallie TB. Gout: epitome of painful arthritis. Metabolism 2010;59:S32-6.
32. Cronstein BN, Sunkureddi P. Mechanistic aspects of inflammation and clinical management of inflammation in acute gouty arthritis. J Clin Rheumatol 2013;19:19-29.
33. Torres R, Macdonald L, Croll SD et al. Hyperalgesia, synovitis and multiple biomarkers of inflammation are suppressed by interleukin 1 inhibition in a novel animal model of gouty arthritis. Ann Rheum Dis 2009;68:1602-8.
34. So A, De Smedt T, Revaz S et al. A pilot study of IL-1 inhibition by anakinra in acute gout. Arthritis Res Ther 2007;9:R28.
35. Lee YM, Kang SM, Lee SR et al. Inhibitory effects of TRPV1 blocker on UV-induced responses in the hairless mice. Arch Dermatol Res 2011;303:727-36.
36. Bolcskei K, Helyes Z, Szabo A et al. Investigation of the role of TRPV1 receptors in acute and chronic nociceptive processes using gene-deficient mice. Pain 2005;117: 368-76.
37. Russell FA, Schuelert N, Veldhoen VE et al. Activation of PAR(2) receptors sensitizes primary afferents and causes leukocyte rolling and adherence in the rat knee joint. Br J Pharmacol 2012;167:1665-78.
38. Cao T, Pinter E, Al RS et al. Neurokinin-1 receptor agonists are involved in mediating neutrophil accumulation in the inflamed, but not normal, cutaneous microvasculature: an in vivo study using neurokinin-1 receptor knockout mice. J Immunol 2000;164:5424-9.
39. Knotkova H, Pappagallo M, Szallasi A. Capsaicin (TRPV1 agonist) therapy for pain relief: farewell or revival? Clin J Pain 2008;24:142-54.
40. Hsieh YL, Chiang H, Tseng TJ et al. Enhancement of cutaneous nerve regeneration by 4-methylcatechol in resiniferatoxin-induced neuropathy. J Neuropathol Exp Neurol 2008;67:93-104.
41. Kobayashi K, Fukuoka T, Obata K et al. Distinct expression of TRPM8, TRPA1 and TRPV1 mRNAs in rat primary afferent neurons with adelta/c-fibers and colocalization with trk receptors. J Comp Neurol 2005; 493:596-606.
42. Nigrovic PA, Lee DM. Synovial mast cells: role in acute and chronic arthritis. Immunol Rev 2007;217:19-37.
43. Davis JB, Gray J, Gunthorpe MJ et al. Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature 2000;405:183-7.
44. Amaral FA, Costa VV, Tavares LD et al. NLRP3 inflammasome-mediated neutrophil recruitment and hypernociception depend on leukotriene B(4) in a murine model of gout. Arthritis Rheum 2012;64:474-84.